No photo of Beatriz da Silva Lopes Martins

Beatriz da Silva Lopes Martins

  • PL 56 (Viikinkaari 5)

    00014

    Finland

20172019
If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 317 Pharmacy

International and National Collaboration Publications and projects within past five years.

Publications 2017 2019

  • 6 Article
  • 1 Meeting Abstract
Open Access
File

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis

Turunen, S. P., von Nandelstadh, P., Öhman, T., Gucciardo, E., Seashore-Ludlow, B., Martins, B., Rantanen, V., Li, H., Höpfner, K., Östling, P., Varjosalo, M. & Lehti, K., Dec 2019, In : Cell Death and Differentiation. 26, 12, p. 2577-2593 17 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Ylösmäki, L., Polini, B., Carpi, S., Martins, B., Smertina, E., Feola, S., Fusciello, M., Peltonen, K., Nieri, P., Ylösmäki, E. & Cerullo, V., 23 Oct 2019, In : PLoS One. 14, 10, p. e0224072

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Feola, S., Capasso, C., Fusciello, M., Martins, B., Tähtinen, S., Medeot, M., Carpi, S., Frascaro, F., Ylösmaki, E., Peltonen, K., Pastore, L. & Cerullo, V., 2018, In : OncoImmunology. 7, 8, 10 p., 1457596.

Research output: Contribution to journalArticleScientificpeer-review

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Ylösmäki, E., Malorzo, C., Capasso, C., Honkasalo, O., Fusciello, M., Martins, B., Ylösmäki, L., Louna, A., Feola, S., Paavilainen, H., Peltonen, K., Hukkanen, V., Viitala, T. & Cerullo, V., 5 Sep 2018, In : Molecular therapy. 26, 9, p. 2315-2325 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File